Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Maka S Hedrington, Ana Tsiskarishvili & Stephen N Davis. (2018) Subcutaneous semaglutide (NN9535) for the treatment of type 2 diabetes. Expert Opinion on Biological Therapy 18:3, pages 343-351.
Read now
Read now
Articles from other publishers (7)
Kendra J. Kamp, Hailey Morgan, Linda Yoo, Sean A. Munson, Margaret M. Heitkemper & Rona L. Levy. (2022) Symptom management needs of patients with irritable bowel syndrome and concurrent anxiety and/or depression: A qualitative study. Journal of Advanced Nursing 79:2, pages 775-788.
Crossref
Crossref
Serap Parlar Kılıc, Nermin Kılıç, Sibel Sevinç & Cihat Demirel. (2020) A Qualitative Study of the Experiences of Complementary and Alternative Medicine of Patients With IBS-C. Holistic Nursing Practice 34:5, pages 291-300.
Crossref
Crossref
Serap Parlar Kılıc, Nermin Kılıç, Sibel Sevinç & Cihat Demirel. (2020) A Qualitative Study of the Experiences of Complementary and Alternative Medicine Use in Patients With IBS-C. Holistic Nursing Practice 34:3, pages 171-179.
Crossref
Crossref
Suzanne Bakken, Theresa A. Koleck, Caitlin Dreisbach & Kathleen T. Hickey. 2020. Genomics of Pain and Co-Morbid Symptoms. Genomics of Pain and Co-Morbid Symptoms
239
255
.
Gregory S Sayuk, Ray Wolf & Lin Chang. (2017) Comparison of Symptoms, Healthcare Utilization, and Treatment in Diagnosed and Undiagnosed Individuals With Diarrhea-Predominant Irritable Bowel Syndrome. American Journal of Gastroenterology 112:6, pages 892-899.
Crossref
Crossref
Michael Horowitz, Vanita R. Aroda, Jenny Han, Elise Hardy & Chris K. Rayner. (2017) Upper and/or lower gastrointestinal adverse events with glucagon-like peptide-1 receptor agonists: Incidence and consequences. Diabetes, Obesity and Metabolism 19:5, pages 672-681.
Crossref
Crossref
Christopher K. Rayner, Karen L. Jones, Tongzhi Wu & Michael Horowitz. (2017) Gut feelings about diabetes and GLP-1 receptor agonists: lessons to be learnt from studies in functional gastrointestinal disorders. Diabetes, Obesity and Metabolism 19:3, pages 309-312.
Crossref
Crossref